Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients
Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
The purpose of the present study was to investigate the predictive value of the risperidone metabolic ratio for the individual
CYP2D6
genotype.
Methods
The determination of risperidone, 9-hydroxyrisperidone, and
CYP2D6
genotype was performed in 89 schizophrenic patients. The receiver operator characteristic (ROC) method...
Alternative Titles
Full title
Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_522863
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_522863
Other Identifiers
ISSN
0031-6970
E-ISSN
1432-1041
DOI
10.1007/s00228-014-1664-3
